Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Director operating in the Health Care space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Paul Agapow
Health Informatics Director of AstraZeneca
Originally a labcoat-wearing biochemist and immunologist, Paul fell sideways into using computers for biology, at first for evolutionary biology and infectious disease. In more recent years, his work has focused on precision medicine and biomedical analytics.
Follow Paul Agapow:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Vincenzo Garzya
Patient Centricity Excellence Director of AstraZeneca
Follow Vincenzo Garzya:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Claus Bendtsen
Executive Director of AstraZeneca
Claus Bendtsen heads Quantitative Biology as part of Discovery Sciences within AstraZeneca. His department provides global support in areas of informatics, mathematical modelling, image analytics and non-clinical statistics. Prior to joining AstraZeneca he held positions at Novartis and Merck & Co. Earlier in his career he co-founded three start-ups and worked in academia. He holds a Ph.D. in applied mathematics and an MBA.
Follow Claus Bendtsen:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Sheena Behn
Global Supply Director of AstraZeneca
Sheena Behn is an established global leader in the Pharmaceutical Industry with significant supply chain, manufacturing and development experience and expertise. She has worked at AstraZeneca for 20 years. Sheena is currently VP Therapy Area Supply (for CVRM/INA Therapy Areas) in Operations for AstraZeneca, and the Operations Executive Sponsor for Risk, based in the UK. She was previously based in Gothenburg as VP R&D Supply Chain (2013-2015), running the global group for Clinical Supply at AZ; and before that VP for Wuxi Manufacturing site for 3 years, based in China (2010-2012). Sheena is a Pharmacist who started her career working in London hospitals, before working in pharmaceutical development with GSK and then AZ before joining Operations in 2007.
Follow Sheena Behn:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Matthew Bonam
Pharmaceutical Project Director of AstraZeneca
Follow Matthew Bonam:
About AstraZeneca, AstraZeneca, AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Louise Almond
Associate Director, Process Sciences of Allergan
Follow Louise Almond:
About Allergan, Pharmaron: Allergan is a global pharmaceutical company.
Stefano Ragni
Director – Global Supply Chain Process Lead of GSK
Stefano Ragni is Global business process owner in GSK for Supply Chain Planning processes, including architecture, people’s roles & responsibilities, cross-functional integration and capability built to enable the business model. Stefano led similar programmes and held operational leadership roles for Integrated Business Planning and Demand Planning in other industries, such as FMCG (eg Heinz) and Automotive (eg Goodyear Dunlop). Beyond his integrated Supply Chain leadership skills, Stefano’s background includes roles in finance, capital engineering and systems implementation.
Follow Stefano Ragni:
About GSK: GSK Venture Fund is a Massachusetts-based venture capital fund focused on investments within the area of bioelectronics.
Adrian Phipps
Global SEO Director of GSK
Adrian is a highly experienced and transformational SEO professional with over 19 years hands-on experience. Starting his career with digital media agencies before progressing client side delivering digital and SEO solutions for the likes of Pfizer, BBC, Volvo, Eurotunnel, Saga and now GSK. Adrian’s most recent achievements have been to drive organic traffic for Saga from 300K sessions per month to over 1 million session per month in 18 months. Moreover, in the same time driving quick answer results from a standing start of 0 to now over 600.
Follow Adrian Phipps:
About GSK: GSK Venture Fund is a Massachusetts-based venture capital fund focused on investments within the area of bioelectronics.
Chris Bonnett
Projects Director of GE Healthcare
Chris Bonnett is a project director at GE Healthcare.
Follow Chris Bonnett:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Ilaria Grizzi
Director, System Integration of Illumina
Follow Ilaria Grizzi:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Guy Whittaker
Non-Exec Director of Digime
Follow Guy Whittaker:
About Digime: Digi.me allows consumers to gather their personal data and share it with businesses in a mutually beneficial value exchange.
Pascal Wheeler
Creative Director of Digime
Highly innovative, creative, and passionate about design, usability and the user journey, Pascal is responsible for all of digi.me’s application and user interface design, as well as the design of supporting websites and marketing material.
Follow Pascal Wheeler:
About Digime, iBundle: Digi.me allows consumers to gather their personal data and share it with businesses in a mutually beneficial value exchange.
David Clark
Independent Non-Executive Director of Constellation Healthcare Technologies
A fund manager for 25 years, David Clark began his career with six years at Scottish Mutual as an investment analyst before joining Ignis Asset Management (formerly Resolution) where he worked from 1993 until September 2014. At Ignis he was responsible for the UK Smaller Companies quoted investments across all sectors. His universe of potential investment candidates included not only those stocks quoted in FTSE UK Small Cap Index but also the Fledgling Index and companies quoted on AIM. His performance resulted in him being ranked number two Fund Manager in the UK (2009) across all sectors by Citywire. David graduated from Glasgow University with a Bachelor of Accountancy Degree and also holds an MSc in Investment Analysis from Stirling University.
Follow David Clark:
About : Constellation Healthcare Technologies provides a holistic, integrated suite of practice management support services to hospitals.
Mark Cooper
Vice President and Managing Director, Avery Europe and Asia Pacific of CCL Industries
Mark Cooper is a Vice President and Managing Director, Avery Europe and Asia Pacific at CCL Industries.
Follow Mark Cooper:
About Avery, CCL Industries: CCL is the largest label company in the world and provides innovative solutions.
Jamie Robinson
Vice President and Managing Director, Home & Personal Care Europe of CCL Industries
Jamie Robinson is a Vice President and Managing Director, Home & Personal Care Europe at CCL Industries.
Follow Jamie Robinson:
About CCL Industries: CCL is the largest label company in the world and provides innovative solutions.
Parminder Basran
Co-founder and Managing Director of Velos Partners
Parminder Basran is the Founder & Managing Partner at VGC Partners.
Follow Parminder Basran:
About Iconic Images, Kick Game, Round World Entertainment, Twenty Ten Capital, Velos Partners, VGC Partners, WIT Fitness: Velos Partners is a consumer growth capital firm investing in retail innovation, health & wellness, and luxury & entertainment.
Matt Lock
Director of Sales Engineers, UK of Varonis Systems
Matthew has 17 years’ experience in the field of Network Security, which includes extensive contracts with many global businesses, including BP and JPMorgan. Specialising in risk assessment, risk management, policy compliance, security reviews and managing network behaviour anomaly systems, Matthew now leads Varonis’ sales engineering team in the UK, Ireland and Middle East, ensuring the team is helping customers and partners from a range of sectors in data governance projects, and organizing, securing and managing their unstructured data.
Follow Matt Lock:
About Varonis Systems: Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Matt Lock
Director of Sales Engineers, UK of Varonis Systems
Matthew has 17 years’ experience in the field of Network Security, which includes extensive contracts with many global businesses, including BP and JPMorgan. Specialising in risk assessment, risk management, policy compliance, security reviews and managing network behaviour anomaly systems, Matthew now leads Varonis’ sales engineering team in the UK, Ireland and Middle East, ensuring the team is helping customers and partners from a range of sectors in data governance projects, and organizing, securing and managing their unstructured data.
Follow Matt Lock:
About Varonis Systems: Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Sarah Verity-Thomas
Managing Director of Cinven
Sarah is a member of the Investor Relations and Fundraising team and is responsible for Cinven’s client services on behalf of our Limited Partners. Previously, Sarah worked as a Manager in the Private Equity Transaction Services group at KPMG, advising private equity clients on M&A and restructuring deals across a range of sectors. Prior to this, Sarah spent four years with Arthur Andersen, where she worked in the Private Equity Tax group and gained her Chartered Accountancy qualification. Sarah holds an MA in Natural Sciences from Cambridge University. She joined Cinven in 2005.
Follow Sarah Verity-Thomas:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Hugh Langmuir
Director of Cinven
Hugh joined Cinven in 1991 and became Managing Partner in 2009. He is responsible for the execution of the firm’s strategy, the day-to-day management of the firm and the Investment Committee and Portfolio Review Committee. Before joining Cinven, Hugh worked at Bain & Company and Citigroup in London and Paris. Hugh holds degrees from the University of Edinburgh, Harvard University and London Business School.
Follow Hugh Langmuir:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Tarek Bayazid
Managing Director of Cinven
Tarek is a member of the Investor Relations and Fundraising team. Previously Tarek worked as a Vice President in the Alternative Assets Group at Citigroup, advising private equity clients with a broad range of products, including M&A advisory, leveraged finance and private equity fundraising. Tarek holds an MSc in Communications and a BA in History from Boston College. He joined Cinven in 2014.
Follow Tarek Bayazid:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Adam Watkins
Director of Cinven
Adam is a member of the Investor Relations and Fundraising team. Prior to Cinven, Adam worked at Deloitte in the Banking & Capital Markets audit division. Adam has a BSc in Physics from the University of Manchester and is a Chartered Accountant. He joined Cinven in 2014.
Follow Adam Watkins:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Doug Oppenheim
Non Executive Director – Advisor of RwHealth
Doug is a Managing Partner of Fram Investment Partners. He moved into private equity in 2002 having previously worked at Dresdner Kleinwort Benson and Merrill Lynch. A significant proportion of Doug’s career has been focused on investing in and building businesses in healthcare. With interests spanning both the clinical and digital domains, Doug is passionate about the power of technology to transform both health outcomes and the affordability of care. He currently serves on the board of Healthcare at Home, which with 200,000 patients is the UK’s largest provider of complex clinical care in the home; he previously served on the board of Dedalus, one of Europe’s largest health software groups. Doug graduated from Cambridge University with first class honours. He has travelled extensively in the polar regions and has skied to the South Pole. He serves as Chairman of the British Exploring Society, a youth development charity established in 1932.
Follow Doug Oppenheim:
About RwHealth: RwHealth is a provider of healthcare ML and AI driven patient flow, predictive analytics and insights platform in the UK, US and AUZ.
Elena Fernandez Kleinlein
Sr. Director Consumer Scientific Innovation of Johnson & Johnson
Elena is the Senior Director of Consumer Scientific Innovation at Johnson & Johnson Innovation. Her main responsibilities are scouting and evaluating early stage technologies and opportunities and managing external partnerships for the strategic areas within the Consumer Sector. Prior to this role, Elena was the Senior Director of R&D Global Topical Health Care for Johnson & Johnson Consumer & Personal Products. In this position, she was responsible for seeking innovative products and claims pipelines within the franchise and oversaw the product development program for iconic brands such as Band-Aid Adhesive Bandages, Johnson & Johnson’s Red Cross and other regional brands like Compeed, Neosporin and Bengay. Elena has grown in the Johnson & Johnson Family of Companies, previously holding roles of Senior Director R&D EMEA Topical Health, performing as the Worldwide Director Women’s Health R&D, and Manager Baby & Kids R&D EMEA for Johnson & Johnson in Germany. These positions have provided her an in-depth knowledge in Research & Development across different groups as well as launch & commercialization experience of different product categories. She has filed several patents. Elena holds a BS and MS in Food Science & Technology from Technical University Munich, Germany.
Follow Elena Fernandez Kleinlein:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Helene Finney
Director, Functional Screening of UCB
Helene joined UCB (then Celltech) in 1989 after 2 years at the MRC Laboratory of Molecular Biology Cambridge, and has gained expertise in a range of antibody technologies. Her PhD studies at UCB in gene therapy generated the first co-stimulation signal inclusive (now termed “second generation”) CAR-T cell constructs. She has led a variety of antibody technology teams & early stage therapeutic antibody discovery projects for oncology, bone, immunology/inflammation & CNS targets. Helene now leads the UCB Functional Screening project team; combining cutting edge antibody & screening technology to discover break-through bispecific antibody drugs across multiple therapeutic areas.
Follow Helene Finney:
About UCB, UCB: UCB Pharma is a biopharmaceutical and specialty chemical company.
Heresh Rezavandi
Ecosystem Strategic Intelligence Lead, Associate Director of UCB
Heresh Rezavandi is the associate director of ecosystem strategic alliance at [UCB Pharma](https://www.crunchbase.com/organization/ucb-pharma), a biopharmaceutical and specialty chemical company that develops therapeutics for central nervous system and immunological diseases.
Follow Heresh Rezavandi:
About UCB: UCB Pharma is a biopharmaceutical and specialty chemical company.
Gavin Wild
Associate Director of UCB
Follow Gavin Wild:
About UCB: UCB Pharma is a biopharmaceutical and specialty chemical company.
George Sutherland
Company Secretary & Non-Executive Director of TestCard Ltd
An experienced Company Director and a Fellow of the Institute of Directors who has demonstrated many years of success working with major fast moving consumer goods (FMCG) and Medical companies. Personally managed business with most of the major retailers and has many years of experience in dealing with the NHS and Medical markets. Experience in raising corporate finance, pre and post IPO.
Follow George Sutherland:
About : TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Anne Lenihan
Director Regulatory Affairs of Pfizer
Follow Anne Lenihan:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Jeremy Farrar
Director of Wellcome Trust
Former Director, Oxford University Clinical Research Unit, Vietnam, with research interests in infectious diseases, tropical health and emerging infections. 2013, joined the Wellcome Trust; currently, Director. Fellow: Academy of Medical Sciences; The Royal Society. Recipient of numerous awards and honours, including: appointed OBE for services to Tropical Medicine (2005); Memorial Medal and Ho Chi Minh City Medal, Government of Vietnam. Named 12th in the Fortune list of 50 World’s Greatest Leaders in 2015.
Follow Jeremy Farrar:
About Wellcome Trust: Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Ashley Brook
Director of The Phoenix Partnership
Ashley manages the Account Team, and is responsible for setting the strategic direction of the company’s UK and international operations. Ashley joined the company as a Customer Relationship Manager in 2006. Initially, Ashley led on the deployment and sales of SystmOne in the North of the UK. After three years he led a team of 16 Customer Relationship Managers across the UK Portfolio. When TPP’s Account Team was formed in 2013, Ashley became Senior Account Manager. In this new role, Ashley’s responsibilities included setting TPP’s strategic direction, identify new markets, sales and maintaining relationships at all levels along with managing the Account Team. More recently, this has included increasing TPP’s presence in international markets, and has represented the company on several occasions across India and Africa. Ashley became a Director in 2015. Highlights of Ashley’s career at TPP include increasing GP deployments from 104 to 741 across the North region, and increasing TPP’s product range to include, amongst others, mental health, social care and acute solutions. Before joining TPP, Ashley gained a BA Business Studies degree from Leeds Met University.
Follow Ashley Brook:
About The Phoenix Partnership: TPP is a healthcare technology company, dedicated to delivering world class healthcare software in the UK and internationally.
Lynsey Flitton
Associate Director Labeling Strategy Europe of AbbVie
Follow Lynsey Flitton:
About AbbVie: AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Rafael López Schietekat
Founder & Managing Director of Diagnostikare
Follow Rafael López Schietekat:
About Diagnostikare: The first data-driven patient-centric virtual primary care platform in Mexico.
Dennis Engelke
Executive Director, Country Manager Switzerland & Austria of Jazz Pharmaceuticals
Dennis Engelke is the director of business analysis and insight at [Jazz Pharmaceuticals](https://www.crunchbase.com/organization/jazz-pharmaceuticals), an international biopharmaceutical company. Engelke holds an MBA from Uppsala University and an MBA from the University of Hamburg.
Follow Dennis Engelke:
About Jazz Pharmaceuticals: Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
Anna C. Catalano
Board of Director of Mead Johnson Nutrition
Ms. Catalano, age 54, joined the Board on July 21, 2006 and currently serves as a member of the Company’s Governance Committee and Compensation Committee. She was Group Vice President, Marketing for BP plc from 2001 to 2003. Prior to that she held various executive positions at BP and Amoco, including Group Vice President, Emerging Markets at BP; Senior Vice President, Sales and Operations at Amoco; and President of Amoco Orient Oil Company. She currently serves on the Board and the Governance Committee of Mead Johnson Nutrition and Chemtura Corporation and the Compensation Committees of Mead Johnson Nutrition, Chemtura Corporation and Kraton Performance Polymers. She serves on the Executive Committee of the Houston Chapter of the Alzheimer’s Association and serves as a director on the National Board of the Alzheimer’s Association. Ms. Catalano formerly served on the boards of SSL International plc, Hercules Incorporated, Aviva plc and U.S. Dataworks and as an advisory board member of BT Global Services. Ms. Catalano holds a BS degree in Business Administration from the University of Illinois, Champaign-Urbana.
Follow Anna C. Catalano:
About : Mead Johnson Nutrition manufactures and sells infant formula, children’s nutrition, and other nutritional products.
Simon Bennett
Director, International Regulatory Affairs of Biogen Idec
Follow Simon Bennett:
About Biogen Idec: Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Fredrik Cornell
Director Commercial Operations of Healthily by Your.MD
Follow Fredrik Cornell:
About Healthily by Your.MD: Healthily is the world’s first medically approved self-care app designed around you.
Paul Armstrong
Mangaging Director of Permira
Paul is a Managing Director, member of the Financing Group and the Deal Structuring Group, specialising in deal structuring and execution. He has worked on numerous transactions including Akindo Sushiro, Allegro Group, Althea, Corin, Dr. Martens, eDreams OdigeO, Genesys, Iglo Group, I-MED, Just, Magento, NDS, Provimi, Synamedia, Teraco, Tilney and Tricor. Prior to joining Permira, Paul practised law for nine years, specialising in private equity transactions at Fried, Frank, Harris, Shriver & Jacobson and, before that, Ashurst.
Follow Paul Armstrong:
About Permira: Permira is a global growth obsessed private capital investor.
Christopher Crozier
Chief Risk Officer and Managing Director of Permira
Christopher is the Chief Risk Officer of Permira. He focuses on improving and standardising Permira’s risk management function globally. His role covers key areas including reputation, conflicts, compliance, litigation and regulatory matters. Christopher is a member of the ESG group. Prior to joining Permira as a Principal in 2008, Christopher was the Chief Administrative Officer for Emerging Markets (EMEA) at Morgan Stanley, where he was responsible for a number of compliance and risk matters, including helping the firm establish its Middle East offices. Before that, he practised law at Freshfields and Simpson Thacher.
Follow Christopher Crozier:
About Permira: Permira is a global growth obsessed private capital investor.
Simon Hancock
Investor and Director of Amplify Life
Follow Simon Hancock:
About Amplify Life: Amplify Life is an app that provides coaching for fitness and wellbeing.
Rich Khatib
Co-founder and Executive Director of Huma Therapeutics
Drives company strategy, operations and finance. His career in EMEA & US, include CEO of a $1B impact investment foundation of the Oceanic Bank International. Previously he kick-started Mondus, a leading European electronic procurement firm, as vice president and 1st team member. In 2001 Mondus sold to Telecom Italia for a total deal of €400 million, delivering a 10X return on the original investment of VC firm 3i. He studied business in Germany and holds a DPhil majoring in economics from Oxford University.
Follow Rich Khatib:
About Huma Therapeutics: Huma provides a digital health platform used for predictive care and research.
Neil Griffiths
Managing Director, UK of TeleTracking
Neil Griffiths is a seasoned healthcare executive, bringing more than 20 years of public and private sector experience to TeleTracking’s UK operations. In his role as Managing Director, he is leading the UK business and is part of the global TeleTracking senior leadership team. With his deep understanding of hospitals and experience of managing change, Mr. Griffiths ensures that TeleTracking’s approach and solutions are deployed in the most effective way to support long term sustainable impact. Prior to joining TeleTracking, Mr. Griffiths was the Deputy CEO and a board member at University College London Hospitals [UCLH] Foundation Trust, one of the leading acute academic hospital providers in the UK. In that capacity, he was responsible for the development of uclh future, the Trust’s ambitious transformation strategy that combines the creation of new operating processes and use of technology with the development of leadership and change management capabilities. Prior to that, Mr. Griffiths was the entrepreneurial leader and a board member for the McKinsey Hospital Institute (MHI) in the UK. Neil holds an MBA from the University of Westminster and a BSc in Politics from the University of Bristol.
Follow Neil Griffiths:
About TeleTracking: TeleTracking Passionate About Optimizing Hospital Operations & PatientFlow.
Andrew Barker
Co-Founder & Director of Intelligent Ultrasound
Andrew Barker is the Chairman at Oxford Brain Diagnostics .
Follow Andrew Barker:
About Anchard Associates, Brainomix, Intelligent Ultrasound, Oxford Brain Diagnostics: Intelligent Ultrasound develops software that improves the quality, reliability, and diagnostic power of medical ultrasound.
Tim Luker
Senior Director, External Innovation, Global External R&D of Eli Lilly
Follow Tim Luker:
About Eli Lilly: Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Derek Marren
Director – Research IT – Global TA & Biology systems & Data Integration of Eli Lilly
Follow Derek Marren:
About AstraZeneca, Eli Lilly: Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Mark Baker
Centre for Clinical Practice Director of National Institute for Health and Care Excellence (NICE)
Mark is the Director of the Centre for Clinical Practice (CCP) and is responsible for designing and operating methods and systems to produce clinical guidelines for the NHS. CCP is also responsible for the work of the Medicines and Prescribing Centre including summaries of evidence on new medicines and unlicensed and off-label medicines and the management of the contract for the British National Formulary. Before joining NICE, Mark was Lead Cancer Clinician at the Leeds Teaching Hospitals and National Clinical Lead for Cancer Peer Review. He has previously worked in transplantation, academic medicine and public health medicine and was Chief Executive of Bradford Teaching Hospitals for six years and a Director of Research and Development.
Follow Mark Baker:
About National Institute for Health and Care Excellence (NICE): The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
Jane Gizbert
Communications Director of National Institute for Health and Care Excellence (NICE)
Jane Gizbert joined NICE in 2008 and is responsible for the delivery of the institute’s strategic communications programme. Jane graduated from the University of New Brunswick in Canada with an BA Honours degree in Political Science. She subsequently obtained an MA in this field from Carleton University in Ottawa and went on to undertake a graduate journalism programme at the same university. Immediately before joining NICE, Jane was head of corporate communications at the Medical Research Council, the UK’s largest publicly funded medical research organisation. Her remit covered the full spectrum of corporate communications, from strategic development, public involvement and consultation, to media relations and brand management. Jane has worked extensively in the political field in Canada, including as Press secretary for the official opposition and former prime minister of Canada, and as Director of communications, Canadian Federation of Labour. Jane has also held senior positions in charitable organisations including the Scout Association and the International Planned Parenthood Federation.
Follow Jane Gizbert:
About National Institute for Health and Care Excellence (NICE): The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
Carole Longson
Health Technology Evaluation Centre Director of National Institute for Health and Care Excellence (NICE)
Carole is Director of the Centre for Health Technology Evaluation at NICE. She has a doctorate in Pharmacology and spent 8 years at GlaxoSmithKline Research working on the development of novel pharmaceuticals in various therapeutic areas. Carole has previously been involved in health technology assessment as Director of the Evidence Research Unit. She contributes to a number of international policy forums, including the WHO advisory group on Priority Medical Devices and the Scientific Committee of the Innovative Medicines Initiative. She is Honorary Professor of Health Technology Assessment at the University of Manchester, UK and currently President of Health Technology Assessment International.
Follow Carole Longson:
About Health Technology Assessment International, National Institute for Health and Care Excellence (NICE), University of Manchester: The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
Alexia Tonnel
Director of Evidence Resources of National Institute for Health and Care Excellence (NICE)
Alexia Tonnel is director of Evidence Resources. She is responsible for the delivery of the NHS Evidence and UK PharmaScan services and leads the information management and technology, user research and information services resources of NICE. Alexia studied business and management in France after which she completed a Master of Science in International Accounting and Finance at the London School of Economics and Political Science. Before joining NICE, Alexia was a Director with Deloitte where she advised a range of clients in the healthcare and life science industries on policy and strategy development as well as programme implementation.
Follow Alexia Tonnel:
About National Institute for Health and Care Excellence (NICE): The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
David Jackson
Agency Commercial Director of United Drug plc
Follow David Jackson:
About United Drug plc: United Drug plc ensures the right products are delivered to the right people at the right time, at the right price.
Peter Lemon
Purchasing Director, United Drug Sangers of United Drug plc
Peter was educated at Annadale Grammar School and when he left school at the age of 18, started working in the Pharmaceutical Sector in the UK as a Trainee Buyer. Most of Peter’s working life has been in the Pharmaceutical Distribution sector with over 40 years’ experience. Peter commenced employment with Sangers in 1993 as a Purchasing Manager and was appointed to the position of Purchasing Director in 1998. Peter is a member of Belvoir Park Golf Club and enjoys playing golf there on a regular basis. His other hobbies and interests include Hockey, Reading and Travel.
Follow Peter Lemon:
About United Drug plc: United Drug plc ensures the right products are delivered to the right people at the right time, at the right price.
Edwin Bleakley
Operations Director, Sangers of United Drug plc
Edwin was educated at Methodist College in Belfast. He was employed by the Northern Bank, Munster Simms and then AAH Pharmaceuticals as General Manager for 14 years before joining Sangers in 2000. Edwin has a keen interest in music and has been a church organist for many years, now playing in the church on the oldest Christian site in Ireland where St. Patrick started his mission, at Saul near Downpatrick. He has rescued and restored a 1954 Triumph TR2 sports car which he still enjoys driving. Edwin has a large garden which requires significant time commitment. Edwin has three grown up children, two living in Northern Ireland and one in Australia, and five grand-children.
Follow Edwin Bleakley:
About United Drug plc: United Drug plc ensures the right products are delivered to the right people at the right time, at the right price.
Richard Whitley
Member of the Board of Directors of Gilead Sciences
Whitley joined Gilead’s Board of Directors in 2008. He is a Distinguished Professor, Loeb Scholar Chair in Pediatrics; Director, Division of Pediatric Infectious Diseases; Vice-Chair, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Senior Scientist, Cancer Research and Training Center; Associate Director for Clinical Studies, Center for AIDS Research; and Co-Director, Center for Emerging Infections and Emergency Preparedness (CEIEP) for the institution. Whitley has held responsibility for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group, is a past President of the International Society of Antiviral Research, chairs the Board of Scientific Counselors for the National Center for Infectious Diseases of the U.S. Centers for Disease Control and Prevention and is President of the Board of the Infectious Diseases Society of America.
Follow Richard Whitley:
About : Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Steve Lane
Commercial Director UK & Europe of Quanta
Follow Steve Lane:
About Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Kruti Popat
Director, Customer Insights & Engagement of Galapagos
Follow Kruti Popat:
About Galapagos: Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Keith Grimes
Clinical Innovation Director of Babylon
Keith Grimes is the clinical innovation director at Babylon Health.
Follow Keith Grimes:
About Babylon, Babylon: Babylon is a world leading, digital-first, value-based care company.
Colleen Johnson
Associate Directorof Toxicology & Consultant of Spinifex Pharmaceuticals
Colleen brings over 20 years of experience in the area of toxicology. She holds a M.S. in Toxicology from University of Arizona as well as Board Certification (D.A.B.T.) and specializes in the development of nonclinical toxicology testing programs for new drugs. Her activities include preparation of toxicology summaries for Spinifex’s submissions in support of our development candidates, develops study protocols and monitors the company’s toxicology programs.
Follow Colleen Johnson:
About Spinifex Pharmaceuticals: Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Petri Vainio
Managing Director of Essex Woodlands Healthcare Partners
Petri Vainio, M.D., Ph.D. has 25 years of experience as an investor in rapidly growing healthcare companies. Petri Vainio spent more than 10 years as a General Partner of Sierra Ventures, one of Silicon Valley’s leading venture capital firms with over $1 billion under management. While at Sierra, Petri Vainio was a General Partner in five successive funds and led their healthcare investment practice. Petri Vainio has been a lead investor in numerous successful healthcare companies in all sectors of healthcare, including pharmaceuticals, biotechnology, medical devices and healthcare services. He has served on the board of directors of over 20 private and public healthcare companies and has helped these companies raise over $1billion in financing and reach a combined market value of over $30 billion. Petri Vainio sits on the Board of Directors of Molecular Partners. Petri Vainio holds a Doctor of Medicine and a Doctor of Philosophy in biochemistry from the University of Helsinki, and a Masters in Business Administration from Stanford University. Petri Vainio joined Essex Woodlands as Managing Director in the London office in 2004.
Follow Petri Vainio:
About Essex Woodlands Healthcare Partners: Essex Woodlands is a healthcare growth equity and venture capital firm.
Ian Mills
Director of Software Engineering and Co-Founder of Clinpal
Ian has been directly involved in the development of some of the leading, and most advanced EDC systems brought to market in the last 15 years. At eClinicalHealth, he continues to lead from the front by supporting clients integrate and extend their eClinical solutions. Ian is an expert in agile software development methods, and besides his hands-on technical prowess he has take the lead in ensuring organizations he works with have bullet proof auditability throughout their product development lifecycle. All work carried out at eClinicalHealth follows either our own rigorous agile Software Development LifeCycle, or, if preferred our sponsors. Ian’s EDC products have been used globally by companies such as Roche, Novartis, Merck and Johnson & Johnson. Ian is a master of CDISC standards – ODM specifically – as well as Web technologies for regulated industries that include; RUP, XP, UML, SCRUM, Agile Development, JEE (JPA, JSF, JSP, JMS, JMX, JTA), Spring Framework, Eclipse, Hibernate, Tapestry, Web Services, JavaScript, Ajax, GWT, JQuery, SQL (Oracle, DB2, MySQL), XML, NoSQL Databases (ObjectStore, Mongo, CouchDB), C/C++, Groovy, Python. Besides Ian’s computing language proficiency, Ian is also fluent in both English and German.
Follow Ian Mills:
About Clinpal: Clinpal is a leading cloud-based digital patient recruitment and engagement platform.
Mark Jenkins
UK Managing & Medical Director of Oviva
Co-founder at Oviva – a digital health company using technology to digitise the dietetic care pathway.
Follow Mark Jenkins:
About Oviva: Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform.
Tarlochan Toor
Medical Director & Co-founder of MedicSpot
Follow Tarlochan Toor:
About MedicSpot: MedicSpot gives patients convenient and quick access to healthcare using the latest advancements in telemedicine
Philippa Jayanathan
Director Of Operations – Central London Community Healthcare NHS Trust of National Health Service
Follow Philippa Jayanathan:
About National Health Service: NHS is the UK’s biggest health website which employs people with a wide range of skills from software development to journalism.
Jennifer Hersch
Co-Founder & Director of Ethos
Follow Jennifer Hersch:
About Ethos: ETHOS is the ultimate yoga fitness hybrid experience with all one needs.
Ann Maitland
Group Director Global Operations of BSN Medical
Ann Maitland joined BSN medical in 2001. Beginning her career with Smith & Nephew Textiles in 1974 within the Surgical Dressings business, she held various positions within a manufacturing capacity before being promoted to Manufacturing Director of the Medical Fabrics Division in 1998. Following the formation of BSN medical in 2001, Ann had subsequent responsibility as VP Operations within the Orthopaedics global business unit. In 2006, she was appointed Senior VP responsible for Global Operations. She continues to manage the operations side of the business today. In her role as EVP Global Operations, Ann is responsible for Global Logistics, Global Procurement, Global Supply Chain and Advanced Manufacturing Engineering.
Follow Ann Maitland:
About BSN Medical: BSN Medical is a global leader in the worldwide healthcare market specialising in the areas of Compression Therapy.
Danilo Casadei Massari
Board of Directors of TargEDys
Follow Danilo Casadei Massari:
About BCD Bioscience, Nemysis: TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.
Lana Ghanem
Founder & Managing Director of Hikma Ventures
Lana is managing director at Hikma Ventures which she helped establish in 2015. Lana started her career at Hikma Pharmaceuticals PLC in 2012 as the Assistant to the CEO and Director of Corporate Strategy & Development where she worked on strategic projects across the company’s various functions including strategy, M&A, operations and finance. Prior to joining Hikma, Lana worked as a Financial Analyst in the Mergers and Acquisitions department at Dresdner Kleinwort Investment Bank in London where she worked on transactions for clients across multiple industries. Lana holds an MBA from Harvard Business School (HBS) and a Bachelors of Commerce degree from McGill University.
Follow Lana Ghanem:
About Hikma Ventures: Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Karen Harwood
Director and Co-Founder of Oodee
Follow Karen Harwood:
About Oodee: allergen neutral skincare – next generation clean beauty
Victoria Tydeman
Director and Co-Founder of Oodee
Follow Victoria Tydeman:
About Oodee: allergen neutral skincare – next generation clean beauty
Andrew Gore
Non Executive Director of Genmed
Follow Andrew Gore:
About Genmed: Genmed is a provider of vendor-neutral, flexible, scalable managed services to the NHS, Health Boards, and private healthcare organizations.
Suman Saha
Co-Founder, Medical Director of Doctify
Follow Suman Saha:
About Doctify: Doctify provides a solution for the millions of patients who want to search and compare healthcare and social care providers online.
Katherine Ward
Chief Commercial Officer, Managing Director UK & Europe of Healthy.io
Follow Katherine Ward:
About Healthy.io: Healthy.io converts smartphone cameras into a clinical grade medical device.
Mathieu de Beaumont
Co-Founder / Director of Dementech
Co-Founder of Dementech Neurosciences
Follow Mathieu de Beaumont:
About : Neurology & Psychology experts
Michel Rabhi
Founder and Director of Dementech
Owner and Director at Dementech Neurosciences
Follow Michel Rabhi:
About : Neurology & Psychology experts
Nikunj Sondagar
Co-Founder & Non Executive Director of Brushlink
Follow Nikunj Sondagar:
About AUXO, Brushlink, Healthcare Angels Network, Medicalsupply, Tooth Wise, Wise360: Brushlink is a health and wellness company that specializes in the fields of oral care and dental insurance markets.
Paul Marran
Director of The Learning Clinic Ltd.
Follow Paul Marran:
About The Learning Clinic Ltd.: The Learning Clinic, a System C company, is a healthcare improvement organisation.
Jonathan Tobin
Managing Director of Arix Bioscience
Jonathan specialises in therapeutics and diagnostics investments and has a background in medical research and drug discovery. Prior to joining Imperial Innovations he worked at MRC Technology, sourcing and evaluating new opportunities for small molecule and antibody drug discovery worldwide. He has a PhD in molecular medicine from UCL, and undertook post-doctoral research at the Cancer Research UK LRI. He has published in journals including New England Journal of Medicine, Nature Genetics, and PNAS. Jonathan has a First Class degree in Biological Science from Oxford University and an MBA with Distinction from Imperial College.
Follow Jonathan Tobin:
About Arix Bioscience: Arix Bioscience is a healthcare and life science company.
Peter Maskell
Managing Director of Koninklijke Philips
Follow Peter Maskell:
About Koninklijke Philips: Koninklijke Philips is a technology company that provides healthcare, consumer lifestyle, and lighting products, solutions, and services.
Hayden Vivash
Financial Director of Koninklijke Philips
Follow Hayden Vivash:
About Koninklijke Philips: Koninklijke Philips is a technology company that provides healthcare, consumer lifestyle, and lighting products, solutions, and services.
Martin Armstrong
Legal Director/Company Secretary of Koninklijke Philips
Follow Martin Armstrong:
About Koninklijke Philips: Koninklijke Philips is a technology company that provides healthcare, consumer lifestyle, and lighting products, solutions, and services.
Nick Bolas
Founder & Director of Hallmarq Veterinary Imaging
Nick Bolas is the Founder and Director at Hallmarq Veterinary Imaging Ltd.
Follow Nick Bolas:
About Hallmarq Veterinary Imaging: Hallmarq Veterinary Imaging is a global leader in innovative diagnostic imaging.
Raj Vora
Founder & Managing Director of Revital
Follow Raj Vora:
About Revital: Revital is an independent company with a mission to care for the wellbeing and health of our customers.
Mark Jopling
Clinical Director of DocTap
Mark has a wealth of GP experience in both the NHS and private practice. Mark ensures that DocTap meets the highest standards of clinical safety, governance and compliance. He is thrilled to be helping provide convenient, affordable and above all excellent GP services to people in London.
Follow Mark Jopling:
About DocTap: DocTap provide convenient, expert GP care from their network of central London clinics.
Richard Durbin
Informatics Director of Congenica
Richard is a Group Leader of the Human Genetics Programme at the Wellcome Trust Sanger Institute, a Fellow of the Royal Society, and a Member of EMBO. A pioneer in the industry, he has developed sequence data analysis tools that are now standards in the field. His current research focuses on human genetic variation by large scale genome-wide re-sequencing. Richard has led the international 1000 Genomes Project and the UK10K Genome Project, and has made significant contributions to the Ensembl resource for vertebrate genome annotation, and the TreeFam and Pfam databases.
Follow Richard Durbin:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Matthew Hurles
Scientific Director of Congenica
Matt is Senior Group Leader at the Wellcome Trust Sanger Institute and a leader in the Deciphering Developmental Disorders, 1000 Genomes and UK10K projects. He has pioneered the analysis of whole exomes in clinically relevant disorders that previously failed diagnostic methods, and has led an initiative to characterise structural variation in the human genome, and integrate this knowledge into disease and population genetic studies. Matt has been awarded the Balfour Lecture by the Genetics Society and the Crick Lecture prize for accomplishments in genetics by the Royal Society.
Follow Matthew Hurles:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Philip Beales
Medical Director of Congenica
Phil is a consultant physician and Professor of Medical and Molecular Genetics at the UCL Institute of Child Health (ICH), an NIHR Senior Investigator, an Honorary Consultant in Clinical Genetics at Great Ormond Street Hospital (GOSH) and the lead on Personalised Medicine for UCL. He is an internationally recognized expert in the genetics and pathogenesis of ciliopathies and pioneering use of next generation sequencing in mapping disease genes in this area.
Follow Philip Beales:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Luke Hares
Technology Director of CMR Surgical
Before co-founding CMR he worked for product design companies in the UK and the US, where he worked on medical devices, robotics, ASIC developments and consumer products. Luke believes the best devices are created by combining a detailed knowledge of the unmet needs of the users with the creative application of a broad knowledge of available technology. Regular contact and interaction with the users of the product is essential for this process. Luke is responsible for leading the CMR technology team and has overall responsiblilty for the technology strategy of the company. He is accustomed to championing ideas, communicating technically complex ideas and designing and managing the development of complex systems.
Follow Luke Hares:
About CMR Surgical: CMR Surgical is developing the next-generation surgical robotic system for minimal access surgery.
Elaine Jones
Finance Director of Circle Health
Elaine Jones is a finance director at Circle Health.
Follow Elaine Jones:
About Circle Health: Circle Health is a provider of health care service with investigation and treatment of diseases.
Daniel Couchman Kendall
Managing Director & Founder of Mission Based Media
Follow Daniel Couchman Kendall:
About Mission Based Media: Mission Based Media creates and produces audio content that depends on the organization’s goals.
Ali Ghorbangholi
Founder and Director of GoodSAM
Follow Ali Ghorbangholi:
About Clinic.co, GoodSAM: Alerting medics, tasking volunteers, handling secure live streaming for emergency services.
Alex Cooper
Director of Support and Technical Operations of Lumeon
Alex is a Support and Technical Operations management professional, with over 20 years in the IT and software industries. His range of experience encompasses work with a wide variety of organizations and customers, from small non-profit organization to the largest global companies. His background is in Content Management and enterprise-class infrastructure and applications, with over 10 years’ experience managing multiple technical teams across geographies. Alex has extensive experience implementing scalable support service organizations and processes, focused on delivering positive outcomes for customers. He has developed operationalized partnerships with blue-chip companies including SAP, HP, Cisco and Capita.
Follow Alex Cooper:
About Lumeon, Lumeon: Lumeon is a digital health company providing management care solutions to the healthcare industry.
Hendrik-Tobias Arkenau
Executive Medical Director of Sarah Cannon
Professor Tobias Arkenau joined Sarah Cannon Research Institute as Executive Medical Director in 2010.
Follow Hendrik-Tobias Arkenau:
About HCA International, Sarah Cannon, UCL: Sarah Cannon offers integrated cancer services with convenient access to cutting-edge therapies.
Soren Krogsgaard Thomsen
Co-Founder, CEO and Managing Director of BioMe Oxford
Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.
Follow Soren Krogsgaard Thomsen:
About BioMe Oxford, Vertex Pharmaceuticals: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Michael Buchen
Managing Director of Polar Light Ventures
Michael is the Founder & Managing Director of Polar Light Ventures AG, an investment firm based in Switzerland, focusing on early-stage technology ventures. Previously he was the Managing Director of Dhabi Holdings, a principal investment firm of senior members of the ruling family of Abu Dhabi. He joined Dhabi Holdings from Mubadala Investment Company, where he worked in the Special Situations Team. Before Mubadala, he worked for Roland Berger Strategy Consultants in Europe, China and the Middle East. Michael currently serves or served on the Boards of a number of companies in the MedTech, Software, AdTech, Financial Services, Food & Beverage, Energy, Telecom and Venture Capital space.
Follow Michael Buchen:
About Polar Light Ventures: Principal Investment Company focusing on early stage technology ventures.
Martin Morrow
Group Tax Director and Company Secretary of Huntsworth
Follow Martin Morrow:
About Huntsworth: Huntsworth plc is an international consultancy group focused on public relations and integrated healthcare communications.
Robert Kilgour
Non Executive Director of Storii
Robert is a Scottish serial entrepreneur, investor and property developer who was the founder of Four Seasons Health Care in 1988. He left in 2000 (when Four Seasons had 101 care homes and 6,500 staff) and later made his final financial exit from the company in 2005. Four Seasons is now the UK’s largest care home operator with nearly 400 care homes, some 20,000 beds and employing around 30,000 staff. He is founder and chief executive of Dow Investments, now celebrating its 27th year, the founder and now chairman of Scottish care home operator, Renaissance Care (which operators 12 homes and employs around 800 staff), co-founder and director of video and security systems specialists, NW Systems Group, and founder shareholder and director of Kingdom FM Radio. Robert holds several other
Follow Robert Kilgour:
About : Software for Senior Care
Connor Minney
Co-founder and Director of Operations of Grndhouse
Connor Minney Co-founder and Director of Operations at Grndhouse.
Follow Connor Minney:
About Grndhouse: Grndhouse is an online fitness platform.
Louis Rennocks
Co-Founder and Managing Director of Grndhouse
Louis Rennocks is the Co-founder and managing director of Grndhouse.
Follow Louis Rennocks:
About Grndhouse: Grndhouse is an online fitness platform.
Victoria Ellison
Marketing Director, UK of Equinox Fitness
With over 15 years’ experience in the wellness industry, Vicky Ellison is Marketing Director for global lifestyle leaders Equinox in the UK and a columnist for Well To Do Global and Lucas Hugh. Her career with Equinox has seen her launch and grow new markets for the brand, including London and Vancouver. Prior to this she worked with brands including Third Space, Matt Roberts, Bliss and Elemis. She shares her marketing expertise in a monthly column for Well To Do. Equinox operates 94 upscale, full-service clubs in New York, Los Angeles, San Francisco, Miami, Chicago, Boston, Dallas, Houston, and Washington, DC, as well as international locations in London, Toronto, and Vancouver. The company offers an integrated selection of Equinox-branded programmess, services and products, including strength and cardio training, studio classes, personal training, spa services and products, apparel and food/juice bars. Launching in 2019, Equinox Hotels will cater exclusively to the high-performance traveller to serve as the ultimate hotel destination with a 360-degree lifestyle experience. For more than 25 years, Equinox has consistently offered bespoke experiences and unparalleled services to consumers, developing a lifestyle brand that represents service, value, quality, expertise, innovation, attention to detail, market leadership and results.
Follow Victoria Ellison:
About Equinox Fitness: Equinox Fitness is an American luxury fitness company with its national headquarters in New York.
Bob Pettigrew
Investor Director of Nightingale-EOS Ltd
Bob Pettigrew has more than 30 years experience in the development of emerging businesses. In 1986 he co-founded Generics (aka Sagentia Plc) and was key member of the team that took the company public in December 2000. He is an investor director on the board of a number of technology companies including Odos Ltd., Nightingale-EOS Ltd. and Sunamp Ltd. He was Chairman of Voxar Ltd and managed its $50m trade sale in Sept 2004 and served previously as NXD with Oxonica, Sphere Medical Plc., Zinwave Ltd., and Digital Health Care Ltd. He is a member of the advisory board of Ascendant Corporate Finance as well as being a non executive board member of British Small Companies VCT2 Plc.
Follow Bob Pettigrew:
About ACAL Energy, British Smaller Technology Companies VCT 2, Nightingale-EOS Ltd: Nightingale-EOS Ltd has developed unique laser-based technology for measuring and characterising thin coatings.
Edward Donald
Senior Director International Marketing of Humanscale Corporation
Follow Edward Donald:
About Humanscale Corporation, UK Trade & Investment (UKTI): Humanscale is the premier designer of sustainable ergonomic seating and tools for a more comfortable workplace.
Leigh Phillipson
Director of Partnerships of MoveGB
Follow Leigh Phillipson:
About MoveGB: MoveGB allows you to exercise how, when, and where you want.
